05/09/2024
3:53 PM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
5:45 PM | Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
11:38 AM | Bristol-Myers Squibb (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
6:47 AM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
7:16 AM | Bristol-Myers Squibb (Filer)
| Form DEFA14A | |
04/02/2024
5:37 PM | Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:38 PM | Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/02/2024
5:40 PM | Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:41 PM | Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:43 PM | Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:44 PM | Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:45 PM | Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
4:16 PM | Bristol-Myers Squibb (Filer)
| Form DEF 14A | |
03/28/2024
4:17 PM | Bristol-Myers Squibb (Filer)
| Form DEFA14A | |
03/28/2024
4:19 PM | Bristol-Myers Squibb (Filer)
| Form ARS | |
03/18/2024
4:21 PM | Bristol-Myers Squibb (Filer)
| Form PRE 14A | |
03/18/2024
4:30 PM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
7:56 AM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
8:54 PM | Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:43 PM | Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:21 PM | Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:11 PM | Bristol-Myers Squibb (Issuer)
Poole Ahn Amanda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:40 PM | Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:31 PM | Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:58 PM | BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:00 PM | Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:01 PM | Bristol-Myers Squibb (Issuer)
Hoch Lynelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:46 PM | Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:50 PM | Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:42 PM | Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:43 PM | Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:45 PM | Bristol-Myers Squibb (Issuer)
Hickey Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:52 PM | Bristol-Myers Squibb (Issuer)
Hickey Benjamin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/23/2024
5:03 PM | Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/23/2024
6:34 AM | Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
| Form SC TO-T/A | |
02/16/2024
3:34 PM | Bristol-Myers Squibb (Filer)
| Form 424B5 | |
02/16/2024
10:36 AM | Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
| Form SC TO-T/A | |
02/14/2024
8:07 PM | Bristol-Myers Squibb (Subject)
| Form FWP | |
02/13/2024
10:54 AM | Bristol-Myers Squibb (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2024
7:00 AM | Bristol-Myers Squibb (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/12/2024
6:34 AM | Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
| Form SC TO-T/A | |
Invest in the "Trojan Horse" of Alzheimer's Treatment (Ad) This one tiny Micro-Cap is at the forefront of what may be the most significant development in healthcare since the discovery of antibiotics. Click here and learn how you can invest in this incredible opportunity>>> |
02/05/2024
6:29 PM | Bristol-Myers Squibb (Issuer)
Vousden Karen H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:31 PM | Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:33 PM | Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:10 PM | Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:13 PM | Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:15 PM | Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:17 PM | Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:21 PM | Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:24 PM | Bristol-Myers Squibb (Issuer)
Price Paula A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:26 PM | Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:27 PM | Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:46 AM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
7:13 AM | Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
| Form SC TO-T | |
01/08/2024
9:29 AM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:48 PM | Bristol-Myers Squibb (Issuer)
Poole Ahn Amanda (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
4:38 PM | Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:39 PM | Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:41 PM | Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:42 PM | Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:44 PM | Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:31 PM | Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:33 PM | Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:36 PM | Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
3:22 PM | Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
| Form SC TO-C | |
12/22/2023
3:36 PM | Bristol-Myers Squibb (Filed by)
Karuna Therapeutics, Inc. (Subject)
| Form DFAN14A | |
12/22/2023
3:21 PM | Bristol-Myers Squibb (Filed by)
Karuna Therapeutics, Inc. (Subject)
| Form DFAN14A | |
12/20/2023
5:08 PM | Bristol-Myers Squibb (Issuer)
Hoch Lynelle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/07/2023
5:06 PM | BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:21 PM | BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:22 PM | Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:23 PM | Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
5:32 PM | BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2023
1:38 PM | Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
6:01 PM | Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
5:30 PM | BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
3:30 PM | Bristol-Myers Squibb (Filer)
| Form 8-K/A | |
10/30/2023
4:26 PM | Bristol-Myers Squibb (Subject)
| Form FWP | |
10/30/2023
7:05 AM | Bristol-Myers Squibb (Filer)
| Form 424B3 | |
10/26/2023
11:33 AM | Bristol-Myers Squibb (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023
6:44 AM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
6:13 PM | Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
5:48 AM | Bristol-Myers Squibb (Filed by)
Mirati Therapeutics, Inc. (Subject)
| Form DFAN14A | |
10/04/2023
8:01 PM | Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2023
8:04 PM | Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:29 PM | Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:31 PM | Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:33 PM | Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:34 PM | Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:36 PM | Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:38 PM | Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A ‘DeFi Summer’ Projected! (Ad) Top analysts are predicting DeFi coins to see massive gains in the coming months…
During this dubbed ‘DeFi Summer…’
A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. |
10/03/2023
5:26 PM | Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
4:28 PM | Bristol-Myers Squibb (Issuer)
Powell Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
1:17 PM | Bristol-Myers Squibb (Subject)
Powell Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
6:10 AM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
4:24 PM | Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
2:54 PM | Bristol-Myers Squibb (Subject)
Plenge Robert M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/27/2023
6:50 AM | Bristol-Myers Squibb (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
8:34 PM | Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/05/2023
4:31 PM | Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
